United States· US:72336-032_97745d9b-c2a6-45e3-9e1e-7fabec4681fb
MARPLAN
A isocarboxazid product containing isocarboxazid, registered in United States by Lifsa Drugs LLC. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Isocarboxazid is registered in 3 of 19 countries.
Countries holding a registration under ATC N06AF01 (isocarboxazid), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Isocarboxazid · ATC N06AF01
3 / 19 countries
- Denmark
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ISOCARBOXAZID
- Manufacturer
- Lifsa Drugs LLC
- Country
- United States (US)
- ATC code
- N06AF01
- ATC class
- Isocarboxazid
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc117233603201100 TABLET in 1 BOTTLE, PLASTIC (72336-032-01)
- ndc1172336-032-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
190 interactions on record for isocarboxazid.
Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isocarboxazid · interactions on record
190 records
- 45 severe
- 134 moderate
- 11 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Isocarboxazid in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Denmark · Marplan
- United Kingdom (Northern Ireland) · Isocarboxazid Alliance Pharmaceuticals
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/55afce4a-55cc-403c-a096-fc6ed18273e6 GET /v1/drugs/55afce4a-55cc-403c-a096-fc6ed18273e6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "10",
"substance": "ISOCARBOXAZID",
"productndc": "72336-032",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA011961",
"marketing_category": "NDA"
}See everything about isocarboxazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.